164 related articles for article (PubMed ID: 34913107)
1. Urothelial Carcinoma in an Allograft kidney.
Hejlesen MB; Youssef MH; Bech JN; Mose FH
Case Rep Nephrol Dial; 2022; 12(2):85-89. PubMed ID: 35950049
[TBL] [Abstract][Full Text] [Related]
2. Urological Cancers and Kidney Transplantation: a Literature Review.
Hernández-Gaytán CA; Rodríguez-Covarrubias F; Castillejos-Molina RA; Hernández-Porras A; Tobia I; Dubin JM; Autrán-Gómez AM
Curr Urol Rep; 2021 Dec; 22(12):62. PubMed ID: 34913107
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
4. The candidate for renal transplantation work up: medical, urological and oncological evaluation.
Cabello Benavente R; Quicios Dorado C; López Martin L; Simón Rodríguez C; Charry Gónima P; González Enguita C
Arch Esp Urol; 2011 Jun; 64(5):441-60. PubMed ID: 21705817
[TBL] [Abstract][Full Text] [Related]
5. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
Boissier R; Hevia V; Bruins HM; Budde K; Figueiredo A; Lledó-García E; Olsburgh J; Regele H; Taylor CF; Zakri RH; Yuan CY; Breda A
Eur Urol; 2018 Jan; 73(1):94-108. PubMed ID: 28803033
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
7. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
[TBL] [Abstract][Full Text] [Related]
8. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
9. Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature.
Hubatsch M; Peters R; Maxeiner A; El-Bandar N; Weinberger S; Friedersdorff F
Urol Int; 2020; 104(11-12):997-999. PubMed ID: 32966984
[TBL] [Abstract][Full Text] [Related]
10. Risk of Genitourinary Malignancy in the Renal Transplant Patient.
Jiang S; Regmi S; Jackson S; Calvert C; Jarosek S; Pruett T; Warlick C
Urology; 2020 Nov; 145():152-158. PubMed ID: 32763322
[TBL] [Abstract][Full Text] [Related]
11. Transplant-associated cancer in the era of immune checkpoint inhibitors: Primum non nocere.
Zwald FO
Am J Transplant; 2020 Sep; 20(9):2299-2300. PubMed ID: 32342618
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
